Clinical Proteomics of Breast Cancer
Author Information
Author(s): Baskın Y., Yiğitbaşı T.
Primary Institution: Dokuz Eylul University, Institute of Oncology
Hypothesis
New proteomic techniques can improve the diagnosis, prognosis, and treatment outcomes for breast cancer.
Conclusion
Proteomic methods show promise in identifying biomarkers for early diagnosis and treatment response in breast cancer.
Supporting Evidence
- Proteomic techniques have been applied successfully to classify breast tumors.
- Studies have shown that early diagnosis significantly improves survival rates.
- Proteomic methods can identify biomarkers that predict treatment outcomes.
Takeaway
Scientists are studying proteins in breast cancer to find better ways to diagnose and treat it, like finding special markers that can tell us more about the disease.
Methodology
The review discusses various proteomic techniques and their applications in breast cancer research, including tissue microarrays and mass spectrometry.
Limitations
Current proteomic profiling techniques have not been validated sufficiently for clinical use.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website